By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Animal genetics companies MetaMorphix (MMI) and Stirius have teamed to form AquaAnimal Health, a joint venture that will use MMI's biomarker-based technology to sustain certain characteristics in aquaculture animals such as finfish and crustaceans.

Under the agreement, MMI has granted AcquAnimal Health a license to its proprietary Myostatin technology and an option to its Genius Whole Genome System for use in aquaculture applications.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.